Mistral Therapeutics
San Diego, US · Founded 2011 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
PP
Petpiboon PrasitNamed on SEC filing
BJ
BRADLEY J BOLZONNamed on SEC filing
PP
PETPIBOON PRASITNamed on SEC filing
TA
THOMAS A COLLNamed on SEC filing
Board
JC
CO
JD
BB
Investors · 1
Reported raises · per SEC filings
Form D private placements$36.4M disclosed across 2 rounds · 2011–2018
▶$25.9MraisedJun 2018 · 5 investors · BiotechnologyRule 506(b)
▶$25.9MraisedJun 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy CaldwellExecutive Officer
- Clare OzawaDirector
- Petpiboon PrasitDirector
- Jerel DavisDirector
- Bradley BolzonDirector
- Offering amount
- $59.3M
- Amount sold
- $25.9M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedJun 2014 · 3 investors · BiotechnologyRule 506(b)
▶$10.5MraisedJun 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- BRADLEY J BOLZONDirector
- PETPIBOON PRASITExecutive Officer, Director
- THOMAS A COLLExecutive Officer
- Offering amount
- $19.5M
- Amount sold
- $10.5M
- First sale
- May 2011
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Mistral Therapeutics's investors?
- Mistral Therapeutics's investors include Versant Ventures.
- How much funding has Mistral Therapeutics raised?
- Mistral Therapeutics has disclosed $36.4M raised across 2 rounds.
- Where is Mistral Therapeutics headquartered?
- Mistral Therapeutics is headquartered in San Diego, US.